Abstract Search

Aims: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) increase the risk for diabetic ketoacidosis, particularly in patients with type 1 diabetes (T1DM). We aimed to determine whether SGLT2i use increase the risk of euglycemic diabetic ketoacidosis (euDKA) and to indicate its demographic, clinical features.Methods: We performed a retrospective cohort study of 51 patients over 18 years-old admitted to emergency unit at a tertiary care hospital from 2018...

0 shares

ea0090ep19 | Adrenal and Cardiovascular Endocrinology | ECE2023

21-hydroxylase deficient congenital adrenal hyperplasia in adult endocrinology clinics of turkey: A nationwide multicenter study

Ertorer Melek Eda , Anaforoglu İnan , Yilmaz Nusret , Akkus Gamze , Turgut Seda , Unluhizarci Kursad , Selcukbiricik Ozlem Soyluk , Merdin Fatma Avcı , Karakilic Ersen , Pehlivan Esma , Yorulmaz Goknur , Gul Ozen Oz , Emral Rifat , Kebapci Medine Nur , Acubucu Fettah , Tuzun Dilek , Gorar Suheyla , Topuz Emek , Bagir Gulay Simsek , Genc Selin , Demir Kezban , Tamer Gonca , Yaylali Guzin , Omma Tulay , Firat Sevde Nur , Koc Gonul , Saygili Emre Sedar , Yurekli Banu Sarer

Introduction: Congenital adrenal hyperplasia (CAH) is a group of autosomal recessively inherited disorders that are characterised by inactivating mutations at various steps of adrenal steroidogenic pathways causing defective cortisol biosynthesis. 21-Hydroxylase enzyme deficiency (21-OHd) constitutes more than 95% of all CAH cases.Material & Methods: Medical records of patients with all forms of CAH from 19 adult endocrinology clinics located at six ...

4 shares

Endocrine Abstracts

Changing clinical features of diabetic ketoacidosis: any impact of SGLT2 inhibıtors is there?

21-hydroxylase deficient congenital adrenal hyperplasia in adult endocrinology clinics of turkey: A nationwide multicenter study

BiosciAbstracts